Join advanced therapies stakeholders for the free virtual Advanced Therapies Manufacturing Strategy Summit, July 14-15, to take stock of the first half of 2020 and the short and long term implications of the ongoing COVID-19 pandemic. Registration is free (ven ...
Review the Current Attendee Snapshot for Advanced Therapies Manufacturing Strategy Digital to get an idea of the companies and industry executives you can expect to meet and network with through our virtual, interactive summit. For questions or details pertaining to sponsorship/exhibition, contact us at enquiry@unitelifesciences.com Event details: July 14 -...
In a time where the possibility for face-to-face interaction is limited, Unite Life Sciences understands it’s more important than ever to help you engage qualified decision makers and generate fresh new leads. Ahead of our fall event in Boston, leverage the digital event summit, Advanced Therapies Manufacturing Strategy Digital, July...
The field of gene therapy is growing exponentially, with The first gene therapy study was carried out in 1989 and since then, around 2600 clinical trials have been conducted. To help companies overcome issues surrounding the development and commercialization of gene therapies, the FDA directs considerable effort toward the development...
In an industry as complex and highly regulated as life sciences, how does one get started on their company’s intelligent automation journey? With help from industry experts from companies like Pfizer, MilliporeSigma, and Johnson and Johnson, we put together this industry-specific, step-by-step guide for effectively:Planning & Piloting a new intelligent...
This handbook draws on the discussions of leading experts and real-life experiences to serve as a guide to navigating the challenges of Pharma/CMO relationships and best practices for building long-lasting partnerships.Download this handbook to learn the following: Effectively managing communication with CMOs Handling complex external supplier footprints Defining strategic partnerships...
The outsourcing biologics industry is expected to grow to $87.5 billion by 2027.With the approval of the first recombinant DNA product, Humulin, biologics has brought great enthusiasm and excitement to doctors, patients and others in the pharma field. Utilizing human life tissues, the practice of biologics can ultimately pave the...
The efficient onboarding and management of CMO networks is crucial to ensure that drugs get to market on time and within budget given the increasingly complex factors being applied by sponsors to supplier selection. If Sponsor/CMO partnerships are not managed effectively and are not mutually beneficial, drug development timelines and...
Given that unexpected challenges in CMO relationships can arise anywhere, it is important to devise a crisis management strategy that ensures production suffers as little interruption as possible, whilst protecting the necessary high quality levels. Ensuring that a CMO-related crisis is effectively managed can help save time and money for...